This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Vitamin Shoppe, Inc. Sued By Investor

Stocks in this article: VSI

SAN DIEGO and NORTH BERGEN, N.J., May 10, 2013 /PRNewswire/ --  Shareholder rights attorneys at Robbins Arroyo LLP announce that a purchaser of Vitamin Shoppe, Inc. (NYSE: VSI) securities has filed a complaint in the U.S. District Court for the District of New Jersey.  The complaint alleges that Vitamin Shoppe and certain of its officers and directors violated the Securities Exchange Act of 1934 between May 8, 2012 and February 25, 2013 (the "Class Period"). 


Vitamin Shoppe Accused of Making False and Misleading Statements Concerning the Company's Business and Operations While Insiders Sell Their Stock

The complaint alleges that during the Class Period, Vitamin Shoppe and certain if its officers and directors issued a series of materially false and misleading statements concerning the true nature of the company's operations and sales trends.  Specifically, the complaint alleges that certain officers and directors of the company failed to disclose that Vitamin Shoppe's performance was being negatively impacted because of: (i) competition from discount on-line retailers; (ii) competitor GNC's new discount program; and (iii) declining same-store sales trends.  As a result of these false and misleading statements, Vitamin Shoppe's stock traded at artificially inflated prices during the Class Period, reaching a high of $65.93 per share on February 19, 2013, during which time company insiders sold more than $30 million of their company stock at inflated prices.    

Vitamin Shoppe Stock Price Drops on Slowdown in Revenue Growth

On February 25, 2013, the complaint alleges, Vitamin Shoppe issued financial results significantly below the lower than the strong forward guidance issued throughout the Class Period, revealing the Company's true business health.  On this news, Vitamin Shoppe's stock price dropped 18.76%, or $11.86 per share, to close at $51.36 per share.

If you purchased or otherwise acquired Vitamin Shoppe stock during the Class Period and wish to serve as lead plaintiff, you must act no later than July 8, 2013.  To discuss your shareholder rights, please contact attorney Darnell R. Donahue at (800) 350-6003,, or via the shareholder information form on the firm's website. 

Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law.  The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.  For more information, please go to

Press release link:

Attorney Advertising. Past results do not guarantee a similar outcome.  

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs